围产期糖尿病的新生儿结局与分娩时机依据:一项回顾性队列研究
该回顾性队列研究纳入2011至2021年90185次分娩中4750例糖尿病孕妇,评估仅因糖尿病相关指征在39周前分娩对新生儿结局的影响及临床医生依据。36与37周因糖尿病指征分娩的新生儿重症监护室入住率高于继续妊娠者,38与39周无差异;早期分娩主要依据为血糖控制不佳。
要点
- 仅因糖尿病指征在36或37周分娩的新生儿重症监护室入住率高于同期继续妊娠者。
- 仅因糖尿病指征在38或39周分娩的新生儿重症监护室入住率与继续妊娠者无差异。
- 早期分娩最常见依据为血糖控制不佳(71.4%),客观指标使用较少。
核心结论
- 在合并糖尿病的妊娠中,仅因糖尿病相关指征的早期分娩与新生儿重症监护室入住率、住院时间及新生儿发病率增加相关。
- 临床医生记录中支持糖尿病相关早期分娩建议的客观数据很少。
- 需要额外的临床指南来定义需要39周前分娩的血糖控制不佳。
研究设计与样本
- 回顾性队列研究,纳入2011至2021年90185次分娩中4750例合并糖尿病的单胎、无畸形妊娠。
- 将特定孕周仅因糖尿病相关指征分娩者与继续妊娠者比较,其他产科指征的建议分娩被排除。
主要发现
- 4750例糖尿病患者中30.5%(n=1449)因糖尿病相关指征建议分娩,其中36周2.2%(n=32)、37周7.9%(n=114)、38周9.7%(n=141)、39周63.0%(n=913)。
- 36周因糖尿病指征分娩者新生儿重症监护室入住率62.5% vs 继续妊娠者8.7%(P<.001);37周为25.4% vs 7.2%(P<.001)。
- 38周与39周因糖尿病指征分娩者新生儿重症监护室入住率与继续妊娠者无差异。
- 36周因糖尿病指征分娩者新生儿重症监护室住院时间中位数11.0 vs 继续妊娠者2.8天(P<.001);37周为4.4 vs 2.6天(P=.026)。
- 36、37、38周因糖尿病指征分娩者新生儿低血糖和呼吸窘迫综合征发生率较继续妊娠者显著增加,死产率无差异。
关键数值与推荐
- 美国妇产科医师学会推荐妊娠期糖尿病(需药物治疗)及孕前糖尿病患者在妊娠第39周分娩,血糖控制不佳者可考虑更早分娩。
- 早期分娩主要依据:血糖控制不佳71.4%、母胎医学专家建议38.7%、疑似胎儿巨大儿27.9%。
- 46.7%、32.8%、20.6%的患者分别有1、2、≥3条早期分娩指征记录。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The American College of Obstetricians and Gynecologists recommends delivery in the 39th week of pregnancy for patients with pregestational and medication-controlled gestational diabetes with consideration for earlier delivery among those with poor glucose control. OBJECTIVE: We sought to evaluate the impact of birth before 39 weeks' gestation exclusively for diabetes-related indications on neonatal outcomes and clinician rationale for these recommendations. STUDY DESIGN: This was a retrospective cohort study of all singleton, nonanomalous pregnancies complicated by diabetes. Patients were identified through an obstetrical database containing information of 90,185 births from 2011 to 2021. Patients who delivered in a given week of gestation exclusively for diabetes-related indications were compared with ongoing pregnancies. Recommended births for other obstetrical indications were excluded from the diabetes-related indications cohorts. The primary outcome was neonatal intensive care unit admission. Secondary outcomes included neonatal intensive care unit length of stay, stillbirth, neonatal death, hypoglycemia, respiratory distress syndrome, and shoulder dystocia. For all births before 39 weeks' gestation, the electronic medical records were reviewed to confirm the rationale for the intervention for a diabetes-indicated condition. RESULTS: From the 90,185 recorded births that occurred in 2011 to 2021, 4750 patients with diabetes were identified. Of those, 30.5% (n=1449) had a recommended birth for a diabetes-related indications with 2.2% of those (n=32) occurring at 36 weeks' gestation, 7.9% (n=114) at 37 weeks' gestation, 9.7% (n=141) at 38 weeks' gestation, and 63.0% (n=913) at 39 weeks' gestation. Births that occurred at 36 and 37 weeks' gestation exclusively for diabetes-related indications had higher rates of neonatal intensive care unit admission than the respective ongoing pregnancies (62.5% vs 8.7%; P<.001 and 25.4% vs 7.2%; P<.001). There was no difference in neonatal intensive care unit admission for births at 38 or 39 weeks' gestation when compared with ongoing pregnancy. For neonates born at 36 and 37 weeks' gestation in comparison with ongoing pregnancies, the median neonatal intensive care unit length of stay was 11.0 vs 2.8 days, (P<.001) and 4.4 vs 2.6 days (P=.026), respectively. There were significantly increased rates of neonatal hypoglycemia and respiratory distress syndrome among births that occurred at 36, 37, and 38 weeks' gestation when compared with ongoing pregnancies. There were no differences in the rate of stillbirth in this cohort. Primary factors cited for early birth were poor glycemic control (71.4%), recommendation by a maternal-fetal medicine specialist (38.7%), and suspected fetal macrosomia (27.9%). Overall, 46.7%, 32.8%, and 20.6% of patients had 1, 2, or ≥3 indications, respectively, listed as rationale for early birth. Overall, few objective measures were used to recommend birth before 39 weeks' gestation owing to diabetes. CONCLUSION: In pregnancies complicated by diabetes, early birth exclusively for diabetes-related indications was associated with increased neonatal intensive care unit admission and length of stay and with neonatal morbidity. Little objective data are documented by clinicians to support their recommendations for early birth associated with diabetes. Additional clinical guidelines are needed to define suboptimal glucose control necessitating birth before 39 weeks' gestation.
引用
- Nashif SK, Mahr RM, Tessier KM, et al. Neonatal outcomes and rationale for timing of birth in perinatal diabetes: a retrospective cohort study. Am J Obstet Gynecol MFM. 2023. PMID: 37567447. doi:10.1016/j.ajogmf.2023.101129
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。